BioMedVC

Verified

Location

Switzerland

Investor type

Venture Capital

Current investment status

00 00 00

Website

https://biomedvc.com/en/biomedvc

Linkedin

00 00 00

Submission link

N.A.

Company address

Elisabethenanlage 11, Basel, 4051, Switzerland

Founding year

2002

Twitter

00 00 00

Facebook

00 00 00

Criteria Requirements Match
Regions
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Countries
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Sector
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Impact Area
00 00 00
Stage
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Ticket size
00 00 00
-
00 00 00
USD
00
Monetization model
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Product readiness
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Client types
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Min. revenue
00 00 00
USD
00
Other
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
-

Unlock Free Premium Insights

Discover how well you match with this investor and reach out on the Raise Better platform.

  • Advanced matching algorithm
  • Detailed compatibility scores
  • Priority investor access
Create Free Account
Company Description

BioMedPartners is a healthcare-dedicated venture capital firm that specializes in providing financing to early-stage private companies and spin-offs within the biotechnology, emerging pharmaceutical, medical technology, and healthcare-related industries. With a focus on Switzerland, Germany, and neighboring EU countries, BioMedPartners manages several funds, including BioMedInvest I, II, and III, facilitating the development of innovative medical solutions. The firm emphasizes strategic investments in companies developing cutting-edge technologies and therapies aimed at improving patient outcomes in various healthcare sectors.

Highlights
Invest in private early- to mid-stage human Life Science companies
Focus on Switzerland and surrounding EU countries Germany, Austria, France, Italy and Benelux
Mostly invest in drug development and, to a lesser degree, in diagnostics and medical technology.

Ready to raise better?

Create your Free Account!